These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 29945665)

  • 1. Availability and use of magnesium sulphate at health care facilities in two selected districts of North Karnataka, India.
    Katageri G; Charantimath U; Joshi A; Vidler M; Ramadurg U; Sharma S; Bannale S; Payne BA; Rakaraddi S; Karadiguddi C; Mungarwadi G; Kavi A; Sawchuck D; Derman R; Goudar S; Mallapur A; Bellad M; Magee LA; Qureshi R; von Dadelszen P;
    Reprod Health; 2018 Jun; 15(Suppl 1):91. PubMed ID: 29945665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of facility readiness and provider preparedness for dealing with postpartum haemorrhage and pre-eclampsia/eclampsia in public and private health facilities of northern Karnataka, India: a cross-sectional study.
    Jayanna K; Mony P; B M R; Thomas A; Gaikwad A; H L M; Blanchard JF; Moses S; Avery L
    BMC Pregnancy Childbirth; 2014 Sep; 14():304. PubMed ID: 25189169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: a case study in Zambia.
    Ridge AL; Bero LA; Hill SR
    BMC Health Serv Res; 2010 Dec; 10():340. PubMed ID: 21162717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Availability of treatment for eclampsia in public health institutions in Maharashtra, India.
    Chaturvedi S; Randive B; Mistry N
    J Health Popul Nutr; 2013 Mar; 31(1):86-95. PubMed ID: 23617209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study.
    Oguntunde O; Charyeva Z; Cannon M; Sambisa W; Orobaton N; Kabo IA; Shoretire K; Danladi SE; Lawal N; Sadauki H
    BMC Pregnancy Childbirth; 2015 Jun; 15():130. PubMed ID: 26037906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of care in early detection and management of pre-eclampsia/eclampsia in health facilities in Afghanistan.
    Ansari N; Manalai P; Maruf F; Currie S; Stekelenburg J; van Roosmalen J; Kim YM; Tappis H
    BMC Pregnancy Childbirth; 2019 Jan; 19(1):36. PubMed ID: 30658606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facility and personnel factors influencing magnesium sulfate use for eclampsia and pre-eclampsia in 3 Indian hospitals.
    Barua A; Mundle S; Bracken H; Easterling T; Winikoff B
    Int J Gynaecol Obstet; 2011 Dec; 115(3):231-4. PubMed ID: 21930268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia.
    Aaserud M; Lewin S; Innvaer S; Paulsen EJ; Dahlgren AT; Trommald M; Duley L; Zwarenstein M; Oxman AD
    BMC Health Serv Res; 2005 Nov; 5():68. PubMed ID: 16262902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and management of severe pre-eclampsia/eclampsia in Afghanistan.
    Kim YM; Ansari N; Kols A; Tappis H; Currie S; Zainullah P; Bailey P; van Roosmalen J; Stekelenburg J
    BMC Pregnancy Childbirth; 2013 Oct; 13():186. PubMed ID: 24119329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of magnesium sulphate for the treatment of severe pre-eclampsia and eclampsia.
    Tukur J
    Ann Afr Med; 2009; 8(2):76-80. PubMed ID: 19805935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quality of care to prevent and treat postpartum hemorrhage and pre-eclampsia/eclampsia : an observational assessment in Madagascar's hospitals].
    Bazant E; Rakotovao JP; Rasolofomanana JR; Tripathi V; Gomez P; Favero R; Moffson S
    Med Sante Trop; 2013 May; 23(2):168-75. PubMed ID: 23694783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical practice patterns on the use of magnesium sulphate for treatment of pre-eclampsia and eclampsia: a multi-country survey.
    Long Q; Oladapo OT; Leathersich S; Vogel JP; Carroli G; Lumbiganon P; Qureshi Z; Gülmezoglu AM;
    BJOG; 2017 Nov; 124(12):1883-1890. PubMed ID: 27885772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community health worker knowledge and management of pre-eclampsia in rural Karnataka State, India.
    Ramadurg U; Vidler M; Charanthimath U; Katageri G; Bellad M; Mallapur A; Goudar S; Bannale S; Karadiguddi C; Sawchuck D; Qureshi R; von Dadelszen P; Derman R;
    Reprod Health; 2016 Sep; 13(Suppl 2):113. PubMed ID: 27719678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal and Newborn Health in Karnataka State, India: The Community Level Interventions for Pre-Eclampsia (CLIP) Trial's Baseline Study Results.
    Bellad MB; Vidler M; Honnungar NV; Mallapur A; Ramadurg U; Charanthimath U; Katageri G; Bannale S; Kavi A; Karadiguddi C; Sharma S; Lee T; Li J; Payne B; Magee L; von Dadelszen P; Derman R; Goudar SS;
    PLoS One; 2017; 12(1):e0166623. PubMed ID: 28107350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe.
    Sevene E; Lewin S; Mariano A; Woelk G; Oxman AD; Matinhure S; Cliff J; Fernandes B; Daniels K
    BMJ; 2005 Oct; 331(7519):765-9. PubMed ID: 16195297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium sulphate for treatment of eclampsia: the Nigerian experience.
    Adewole IF; Oladokun A; Okewole AI; Omigbodun AO; Afolabi A; Ekele B; Audu LR; Obed Y
    Afr J Med Med Sci; 2000; 29(3-4):239-41. PubMed ID: 11713998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Situational analysis of facilitators and barriers to availability and utilization of magnesium sulfate for eclampsia and severe preeclampsia in the public health system in Brazil.
    Lotufo FA; Parpinelli MA; Osis MJ; Surita FG; Costa ML; Cecatti JG
    BMC Pregnancy Childbirth; 2016 Aug; 16(1):254. PubMed ID: 27577571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial.
    Altman D; Carroli G; Duley L; Farrell B; Moodley J; Neilson J; Smith D;
    Lancet; 2002 Jun; 359(9321):1877-90. PubMed ID: 12057549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsants for women with pre-eclampsia.
    Duley L; Gulmezoglu AM; Henderson-Smart DJ
    Cochrane Database Syst Rev; 2000; (2):CD000025. PubMed ID: 10796090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years.
    Magpie Trial Follow-Up Study Collaborative Group
    BJOG; 2007 Mar; 114(3):300-9. PubMed ID: 17166220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.